Israel Englander Corcept Therapeutics Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Millennium Management LLC holds 187,800 shares of CORT stock, worth $9.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

187,800

Previous 307,300 38.89%

Holding current value

$9.65 Million

Previous $9.98 Million 12.99%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $1.86 Million - $2.92 Million	-63,075 Reduced 20.86%	239,226 $11.1 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $5.57 Million - $8.64 Million	-250,706 Reduced 45.34%	302,301 $9.82 Million
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $2.89 Million - $3.76 Million	-137,069 Reduced 19.86%	553,007 $13.9 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $4.35 Million - $5.77 Million	-175,383 Reduced 20.26%	690,076 $22.4 Million
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $33.7 Million - $39.5 Million	-1,569,693 Reduced 64.46%	865,459 $19.3 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $43.8 Million - $55.8 Million	2,281,282 Added 1482.6%	2,435,152 $52.7 Million
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $1.37 Million - $2.06 Million	68,618 Added 80.49%	153,870 $3.13 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $13.1 Million - $15.4 Million	-528,757 Reduced 86.12%	85,252 $2.19 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $20 Million - $29.2 Million	-1,153,232 Reduced 65.26%	614,009 $14.6 Million
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $25.9 Million - $39.5 Million	-1,565,894 Reduced 46.98%	1,767,241 $39.8 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $54.9 Million - $74.9 Million	3,210,291 Added 2613.31%	3,333,135 $66 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $268,002 - $306,813	13,618 Added 12.47%	122,844 $2.42 Million
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $1.81 Million - $2.22 Million	90,744 Added 490.99%	109,226 $2.4 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $434,142 - $564,809	18,482 New	18,482 $440,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $2.11 Million - $3.44 Million	-125,895 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $5.45 Million - $8.74 Million	-437,595 Reduced 77.66%	125,895 $2.19 Million
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $2.33 Million - $3.87 Million	212,153 Added 60.38%	563,490 $9.48 Million
Q1 2020 May 14, 2020	SELL	$10.11 - $14.04 $1.19 Million - $1.65 Million	-117,362 Reduced 25.04%	351,337 $4.18 Million
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $2.95 Million - $4.15 Million	-244,817 Reduced 34.31%	468,699 $5.67 Million
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $5.37 Million - $7.56 Million	515,873 Added 261.01%	713,516 $10.1 Million
Q2 2019 Aug 15, 2019	SELL	$9.78 - $12.76 $148,186 - $193,339	-15,152 Reduced 7.12%	197,643 $2.2 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $4 Million - $5.22 Million	-409,478 Reduced 65.8%	212,795 $10 Million
Q1 2019 May 14, 2019	SELL	$10.03 - $15.71 $467,036 - $731,520	-46,564 Reduced 6.96%	622,273 $7.31 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $6.92 Million - $10.5 Million	612,518 Added 1087.59%	668,837 $8.94 Million
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $878,347 - $1.12 Million	-71,585 Reduced 55.97%	56,319 $790,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $7.24 Million - $9.32 Million	-473,504 Reduced 78.73%	127,904 $2.01 Million
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $8.42 Million - $14.7 Million	-576,810 Reduced 48.96%	601,408 $9.89 Million
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $5.22 Million - $6.86 Million	331,287 Added 39.12%	1,178,218 $21.3 Million
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $10.4 Million - $16.3 Million	846,931	846,931 $16.3 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.51B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account